Candida Clinical Trials

1 recruiting

Frequently Asked Questions

Common questions about Candida clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Phase 1Phase 2

A Phase Ib/II Open-label Study of AMO959 With Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in Combination With ARPI in Adult Participants With PSMA-positive mCRPC

PSMA-positive Metastatic Castration Resistant Prostate Cancer (mCRPC) With Prior Exposure to One Prior ARPI Who Are Candidates for Taxane-based Chemotherapy
Novartis Pharmaceuticals123 enrolled2 locationsNCT07226986
Recruiting
Not Applicable

Surgery Versus Best Medical Management for the Long Term Remission of Type 2 Diabetes and Related Diseases (REMISSION)

DiabetesBariatric Surgery Candidate
Laval University408 enrolled1 locationNCT02390973
Recruiting

Gut Microbiota in Metabolic Surgery

Cardiovascular DiseasesHypertensionType 2 Diabetes+3 more
Vanderbilt University Medical Center300 enrolled1 locationNCT05000996
Recruiting

Blood Collection Biorepository for Liver Disease Research

CirrhosisFibrosisHepatitis B+5 more
State University of New York at Buffalo1,000 enrolled1 locationNCT03025074
Recruiting
Not Applicable

The Poor Responders Study

Diabetes Mellitus, Type 2Obesity, MorbidBariatric Surgery Candidate
Imperial College London220 enrolled1 locationNCT05404061
Recruiting

CV Imaging of Metabolic Interventions

Heart FailureCardiovascular DiseasesBariatric Surgery Candidate
The Cleveland Clinic150 enrolled1 locationNCT05650307
Recruiting
Not Applicable

Bariatric Surgery for Fertility-Sparing Treatment of Atypical Hyperplasia and Grade 1 Cancer of the Endometrium

Endometrial CancerAtypical HyperplasiaBariatric Surgery Candidate
University Health Network, Toronto36 enrolled1 locationNCT04008563
Recruiting
Phase 3

DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer

Colorectal, CancerMetastatic CancerOlder Patients+1 more
Leiden University Medical Center587 enrolled36 locationsNCT06275958
Recruiting
Not Applicable

Candida PCR Diagnosis Strategy in Patients From Intensive Care Units

Candida
University Hospital, Toulouse120 enrolled1 locationNCT04874441
Recruiting

Paraoxonase and HDL Qualities in Glycaemia and Inflammation

Diabetes MellitusBariatric Surgery Candidate
Manchester University NHS Foundation Trust600 enrolled1 locationNCT02169518
Recruiting
Not Applicable

Familial Pancreatic Cancer PROPHilation Program in Italy

Candidates for Hereditary Pancreatic Cancer Testing
Associazione Italiana per lo Studio del Pancreas3,000 enrolled1 locationNCT05724992
Recruiting
Phase 3

A Trial of SHR3680 in Prostate Cancer Patients Who Are Candidates for Radical Prostatectomy

Patients With High-risk Localized or Locally Advanced Prostate Cancer Who Are Candidates for Radical Prostatectomy
Jiangsu HengRui Medicine Co., Ltd.1,256 enrolled1 locationNCT05009290